Robert Mather

Robert Mather

Pfizer Inc. - New York / United States
Medical and Health Sciences / Neuroscience
AD Scientific Index ID: 4381155
-
person_outline Robert Mather's MOST POPULAR ARTICLES
1-) Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1. 1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.S Grissmer, AN Nguyen, J Aiyar, DC Hanson, RJ Mather, GA Gutman, ...Molecular pharmacology 45 (6), 1227-1234, 19949631994
2-) Pharmacological profile of the α4β2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aidH Rollema, LK Chambers, JW Coe, J Glowa, RS Hurst, LA Lebel, Y Lu, ...Neuropharmacology 52 (3), 985-994, 20076252007
3-) Pre‐clinical properties of the α4β2 nicotinic acetylcholine receptor partial agonists varenicline, cytisine and dianicline translate to clinical efficacy for nicotine dependenceH Rollema, A Shrikhande, KM Ward, FD Tingley Iii, JW Coe, BT O\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\'Neill, ...British journal of pharmacology 160 (2), 334-345, 20101722010
4-) Novel nonpeptide agents potently block the C-type inactivated conformation of Kv1. 3 and suppress T cell activation.A Nguyen, JC Kath, DC Hanson, MS Biggers, PC Canniff, CB Donovan, ...Molecular pharmacology 50 (6), 1672-1679, 19961591996
5-) Selective inhibition of KCC2 leads to hyperexcitability and epileptiform discharges in hippocampal slices and in vivoS Sivakumaran, RA Cardarelli, J Maguire, MR Kelley, L Silayeva, ...Journal of Neuroscience 35 (21), 8291-8296, 20151112015